Digital health case studyMedical Device

Selecting Personal Health Ventures for Two Priority Therapeutic Areas

Client context: Global medical device leader

Strategic question

Which personal-health ventures are the optimal fit for our two priority therapeutic areas across the major global ecosystems?

Decision enabled

What the client could do next

Enabled BD and franchise teams to enter partnership conversations with a defensible top-10.

Approach

Using HealthTech Alpha’s Alpha Score and proprietary market signals, we evaluated 259 personal-health ventures across three regions and applied strategic, clinical and commercial filters to arrive at a final selection of 10.

Methodology

DefineClarified the strategic question, scope, decision owner and evaluation criteria.

MapIdentified relevant ventures, markets, competitors, partnerships and ecosystem signals.

AssessEvaluated maturity, traction, evidence, strategic fit and operational readiness.

DecideTranslated findings into a decision-ready shortlist, benchmark or recommendation.

Strategic interpretation

Cut through volume to isolate the ventures with the strongest strategic and clinical fit against enterprise criteria.

Key results

GlobalEcosystem coverage

259Ventures evaluated against criteria

10Prioritised shortlist

Structured digital health intelligence, venture evidence, and analyst interpretation for defensible decisions.

Alpha Brief

Turn this case study into your own decision brief

Answer a few prompts and request a scoped Alpha Brief for your market, portfolio, competitive intelligence, or due diligence question.

Build an Alpha Brief

Request a scoped proposal from this case

Selecting Personal Health Ventures for Two Priority Therapeutic Areas

Which personal-health ventures are the optimal fit for our two priority therapeutic areas across the major global ecosystems?

What the client could do next

Approach

Methodology

Strategic interpretation

Overview

Category

Stage

Total Funding

GGA Score